Perampanel for the Treatment of People with Idiopathic Generalized Epilepsy in Clinical Practice.
Eugen TrinkaTaoufik AlsaadiHiroko GojiTaketoshi MaeharaSatoru TakahashiJulia JacobsRosaria RennaFrancisco José Gil-LópezRob McMurrayRicardo Sáinz-FuertesVicente VillanuevaPublished in: Epilepsia (2023)
This subgroup analysis of the PERMIT study demonstrated the effectiveness and good tolerability of PER in people with IGE when administered under everyday clinical practice conditions. These findings are in line with clinical trial evidence, supporting PER's use as broad-spectrum antiseizure medication for the treatment of IGE.